CYSLTR2 and breast carcinoma: Similar to the findings in colon cancer, activating CysLT2R signaling with LTC4 (preferentially binds to CysLT2R, rather than CysLT1R) did not affect cell proliferation or apoptosis of breast cancer cells but reduced cell migration [74].